Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
3.100
+0.060 (1.97%)
Feb 5, 2025, 9:49 AM EST - Market open
Solid Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
88
Market Cap
123.86M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
Novartis AG | 51.72B |
AstraZeneca | 51.21B |
Thermo Fisher Scientific | 42.88B |
Abbott Laboratories | 41.95B |
SLDB News
- 14 days ago - Solid Biosciences: Differentiating Factors Of SGT-212 To Set Itself Apart - Seeking Alpha
- 15 days ago - Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich's Ataxia - GlobeNewsWire
- 20 days ago - Solid Biosciences Outlines Key Priorities for Advancing Diversified Neuromuscular and Cardiac Development Pipeline and Establishing Leadership in Precision Genetic Medicines - GlobeNewsWire
- 27 days ago - Solid Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich's Ataxia - GlobeNewsWire
- 6 weeks ago - Solid Biosciences Added to the Nasdaq Biotechnology Index - GlobeNewsWire
- 7 weeks ago - Solid Biosciences Positioned For Next-Gen Duchenne Muscular Dystrophy Treatment Success: Analyst - Benzinga
- 2 months ago - Solid Biosciences to Participate at Upcoming Investor Conferences - GlobeNewsWire